PFIZER INC Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax of -$1.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax · last filed 2026-08-04
- PFIZER INC other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for the quarter ending 2026-06-28 was -$1.00M, a 103.13% decline year-over-year.
- PFIZER INC other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for the quarter ending 2026-03-29 was -$6.00M, a 110.91% decline year-over-year.
- PFIZER INC other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for the quarter ending 2025-12-31 was $3.00M.
- PFIZER INC other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for the quarter ending 2025-09-28 was -$32.00M, a 176.19% decline year-over-year.
- PFIZER INC other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for fiscal 2025 was $58.00M, a 100.00% increase from fiscal 2024.
- PFIZER INC other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for fiscal 2024 was $29.00M, a 68.82% decline from fiscal 2023.
- PFIZER INC other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for fiscal 2023 was $93.00M, a 65.56% decline from fiscal 2022.
- PFIZER INC other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, tax for fiscal 2022 was $270.00M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$1.00M 10-Q · filed 2026-08-04 | -$7.00M 10-Q · filed 2026-08-04 | -$4.00M derived: sum of 3 quarters · filed 2026-08-04 | -$36.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-29 | -$6.00M 10-Q · filed 2026-05-05 | -$3.00M derived: sum of 2 quarters · filed 2026-05-05 | -$35.00M derived: sum of 3 quarters · filed 2026-05-05 | -$3.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$29.00M derived: sum of 2 quarters · filed 2026-02-26 | $3.00M derived: sum of 3 quarters · filed 2026-08-04 | $58.00M 10-K · filed 2026-02-26 |
| 2025-09-28 | -$32.00M 10-Q · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $55.00M 10-Q · filed 2025-11-04 | $16.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-29 | $32.00M 10-Q · filed 2026-08-04 | $87.00M 10-Q · filed 2026-08-04 | $48.00M derived: sum of 3 quarters · filed 2026-08-04 | $90.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-30 | $55.00M 10-Q · filed 2026-05-05 | $16.00M derived: sum of 2 quarters · filed 2026-05-05 | $58.00M derived: sum of 3 quarters · filed 2026-05-05 | $81.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.00M derived: sum of 2 quarters · filed 2026-02-26 | $26.00M derived: sum of 3 quarters · filed 2026-02-26 | $29.00M 10-K · filed 2026-02-26 |
| 2024-09-29 | $42.00M 10-Q · filed 2025-11-04 | $65.00M derived: sum of 2 quarters · filed 2025-11-04 | $68.00M 10-Q · filed 2025-11-04 | $146.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $23.00M 10-Q · filed 2025-08-05 | $26.00M 10-Q · filed 2025-08-05 | $104.00M derived: sum of 3 quarters · filed 2026-02-26 | $109.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.00M 10-Q · filed 2025-05-05 | $81.00M derived: sum of 2 quarters · filed 2026-02-26 | $86.00M derived: sum of 3 quarters · filed 2026-02-26 | $119.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $82.00M derived: sum of 2 quarters · filed 2026-02-26 | $115.00M derived: sum of 3 quarters · filed 2026-02-26 | $93.00M 10-K · filed 2026-02-26 |
| 2023-10-01 | $5.00M 10-Q · filed 2024-11-04 | $38.00M derived: sum of 2 quarters · filed 2024-11-04 | $16.00M 10-Q · filed 2024-11-04 | $190.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $33.00M 10-Q · filed 2024-08-05 | $12.00M 10-Q · filed 2024-08-05 | $185.00M derived: sum of 3 quarters · filed 2025-02-27 | $257.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | -$21.00M 10-Q · filed 2024-05-08 | $152.00M derived: sum of 2 quarters · filed 2025-02-27 | $224.00M derived: sum of 3 quarters · filed 2025-02-27 | $227.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $173.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $245.00M derived: sum of 2 quarters · filed 2025-02-27 | $248.00M derived: sum of 3 quarters · filed 2025-02-27 | $270.00M 10-K · filed 2025-02-27 |
| 2022-10-02 | $72.00M 10-Q · filed 2023-11-08 | $75.00M derived: sum of 2 quarters · filed 2023-11-08 | $97.00M 10-Q · filed 2023-11-08 | $116.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-07-03 | $3.00M 10-Q · filed 2023-08-09 | $26.00M 10-Q · filed 2023-08-09 | $44.00M derived: sum of 3 quarters · filed 2024-02-22 | $31.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-04-03 | $22.00M 10-Q · filed 2023-05-10 | $41.00M derived: sum of 2 quarters · filed 2024-02-22 | $28.00M derived: sum of 3 quarters · filed 2024-02-22 | $27.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $6.00M derived: sum of 2 quarters · filed 2024-02-22 | $5.00M derived: sum of 3 quarters · filed 2024-02-22 | -$29.00M 10-K · filed 2024-02-22 |
| 2021-10-03 | -$13.00M 10-Q · filed 2022-11-09 | -$14.00M derived: sum of 2 quarters · filed 2022-11-09 | -$48.00M 10-Q · filed 2022-11-09 | -$36.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-07-04 | -$1.00M 10-Q · filed 2022-08-10 | -$35.00M 10-Q · filed 2022-08-10 | -$23.00M derived: sum of 3 quarters · filed 2023-02-23 | -$30.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-04-04 | -$34.00M 10-Q · filed 2022-05-11 | -$22.00M derived: sum of 2 quarters · filed 2023-02-23 | -$29.00M derived: sum of 3 quarters · filed 2023-02-23 | $6.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $5.00M derived: sum of 2 quarters · filed 2023-02-23 | $40.00M derived: sum of 3 quarters · filed 2023-02-23 | $25.00M 10-K · filed 2023-02-23 |
| 2020-09-27 | -$7.00M 10-Q · filed 2021-11-12 | $28.00M derived: sum of 2 quarters · filed 2021-11-12 | $13.00M 10-Q · filed 2021-11-12 | $76.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-28 | $35.00M 10-Q · filed 2021-08-12 | $20.00M 10-Q · filed 2021-08-12 | $83.00M derived: sum of 3 quarters · filed 2022-02-24 | $86.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-29 | -$15.00M 10-Q · filed 2021-05-13 | $48.00M derived: sum of 2 quarters · filed 2022-02-24 | $51.00M derived: sum of 3 quarters · filed 2022-02-24 | $55.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $63.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $66.00M derived: sum of 2 quarters · filed 2022-02-24 | $70.00M derived: sum of 3 quarters · filed 2022-02-24 | $125.00M 10-K · filed 2022-02-24 |
| 2019-09-29 | $3.00M 10-Q · filed 2020-11-05 | $7.00M derived: sum of 2 quarters · filed 2020-11-05 | $62.00M 10-Q · filed 2020-11-05 | $71.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $4.00M 10-Q · filed 2020-08-06 | $59.00M 10-Q · filed 2020-08-06 | $68.00M derived: sum of 3 quarters · filed 2021-02-25 | $96.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $55.00M 10-Q · filed 2020-05-07 | $64.00M derived: sum of 2 quarters · filed 2021-02-25 | $92.00M derived: sum of 3 quarters · filed 2021-02-25 | $20.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $37.00M derived: sum of 2 quarters · filed 2021-02-25 | -$35.00M derived: sum of 3 quarters · filed 2021-02-25 | -$27.00M 10-K · filed 2021-02-25 |
| 2018-09-30 | $28.00M 10-Q · filed 2019-11-07 | -$44.00M derived: sum of 2 quarters · filed 2019-11-07 | -$36.00M 10-Q · filed 2019-11-07 | $18.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-07-01 | -$72.00M 10-Q · filed 2019-08-08 | -$65.00M 10-Q · filed 2019-08-08 | -$10.00M derived: sum of 3 quarters · filed 2020-02-27 | $19.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-04-01 | $7.00M 10-Q · filed 2019-05-09 | $62.00M derived: sum of 2 quarters · filed 2020-02-27 | $91.00M derived: sum of 3 quarters · filed 2020-02-27 | $179.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $55.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $84.00M derived: sum of 2 quarters · filed 2020-02-27 | $172.00M derived: sum of 3 quarters · filed 2020-02-27 | $224.00M 10-K · filed 2020-02-27 |
| 2017-10-01 | $29.00M 10-Q · filed 2018-11-08 | $117.00M derived: sum of 2 quarters · filed 2018-11-08 | $169.00M 10-Q · filed 2018-11-08 | |
| 2017-07-02 | $88.00M 10-Q · filed 2018-08-09 | $140.00M 10-Q · filed 2018-08-09 | ||
| 2016-12-31 | -$158.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |